Cargando…
Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
BACKGROUND: Pharmacokinetics (PK), efficacy, and safety of the opioid analgesic tapentadol in the treatment of moderate-to-severe acute pain have so far not been investigated in pediatric patients <2 years of age. PATIENTS AND METHODS: Two multicenter, open-label trials assessed the pharmacokinet...
Autores principales: | Eissa, Ayman, Tarau, Eva, Beuter, Christoph, Radic, Tatjana, Watson, Estelle, Sohns, Melanie, Lefeber, Claudia, Hammer, Gregory B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853441/ https://www.ncbi.nlm.nih.gov/pubmed/33542653 http://dx.doi.org/10.2147/JPR.S269530 |
Ejemplares similares
-
Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients
por: Muse, Derek, et al.
Publicado: (2019) -
Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020) -
Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial
por: Beuter, Christoph, et al.
Publicado: (2019) -
Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021) -
Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years
por: Jończyk, Renata, et al.
Publicado: (2022)